Podcast Nov 12, 2024

Deadly Prescriptions: What Happens When Doctors Compete for Patients

Tess Vigeland and Molly Schnell
Listen / Subscribe:

When some US states allowed nurse practitioners to prescribe controlled substances without physician oversight, a serious unintended consequence took hold: Doctors found themselves competing with those nurses for patients. Molly Schnell, BFI Saieh Family Fellow and assistant professor at Northwestern University, along with her colleagues—Janet Currie of Princeton and Anran Li of Cornell—examine the resultant uptick in prescriptions in controlled substances, and the impact on patients.

View All Episodes
Related People

More on this topic

Podcast Oct 15, 2024

How Do Buyouts Impact Hospital Performance? Evaluating the Role of Private Equity in Healthcare

Tess Vigeland and Maggie Shi
Private equity investors made some $200 billion worth of healthcare acquisitions in 2021, and $1 trillion worth in the 10 years leading up to 2023. In this episode of The Pie, Maggie Shi, professor at the Harris School of Public...
Topics: Health care
Research Briefs·Sep 25, 2024

Investing in Vaccines to Mitigate Harm from COVID-19 and Future Pandemics

Rachel Glennerster, Catherine Che, Sarrin Chethik, Claire McMahon, and Christopher M. Snyder
During pandemics, rapid vaccination can significantly reduce mortality, economic losses, and societal disruptions. Vaccine manufacturers often lack incentives to expand their speed and capacity, however. This market failure can be addressed with strategic policies that realign incentives both during and...
Topics: Health care
Research Briefs·Sep 4, 2024

Managing Margins: PE Effects on Financial, Physical, and Human Capital

Michael R. Richards, Maggie Shi, and Christopher M. Whaley
Private equity’s influence on hospital performance includes permanent improvements in hospital patient volumes and revenues, reductions in full-time employees, restrained technology adoption, and improved operating margins.
Topics: Health care